MICROSATELLITE STABLE RECTAL CARCINOMA

Clinical trials for MICROSATELLITE STABLE RECTAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new MICROSATELLITE STABLE RECTAL CARCINOMA trials appear

Sign up with your email to follow new studies for MICROSATELLITE STABLE RECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to shrink rectal tumors without chemo

Disease control Recruiting now

This study is testing whether two immunotherapy drugs (botensilimab and balstilimab) can shrink rectal tumors before surgery. Researchers want to see if this approach works for people with a specific type of rectal cancer that doesn't typically respond well to immunotherapy. The …

Matched conditions: MICROSATELLITE STABLE RECTAL CARCINOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MICROSATELLITE STABLE RECTAL CARCINOMA

Get alerted when new MICROSATELLITE STABLE RECTAL CARCINOMA trials appear

New drug combo aims to shrink rectal tumors without chemo